nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—ABCB1—Methylprednisolone—psoriatic arthritis	0.122	0.157	CbGbCtD
Reboxetine—ABCB1—Betamethasone—psoriatic arthritis	0.0795	0.102	CbGbCtD
Reboxetine—ABCB1—Prednisolone—psoriatic arthritis	0.0785	0.101	CbGbCtD
Reboxetine—ABCB1—Prednisone—psoriatic arthritis	0.0741	0.0954	CbGbCtD
Reboxetine—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0733	0.0943	CbGbCtD
Reboxetine—CYP3A4—Triamcinolone—psoriatic arthritis	0.0555	0.0715	CbGbCtD
Reboxetine—CYP3A4—Betamethasone—psoriatic arthritis	0.0476	0.0613	CbGbCtD
Reboxetine—CYP3A4—Prednisolone—psoriatic arthritis	0.047	0.0605	CbGbCtD
Reboxetine—ABCB1—Dexamethasone—psoriatic arthritis	0.0463	0.0595	CbGbCtD
Reboxetine—CYP3A4—Prednisone—psoriatic arthritis	0.0444	0.0571	CbGbCtD
Reboxetine—CYP2D6—Dexamethasone—psoriatic arthritis	0.0436	0.0561	CbGbCtD
Reboxetine—ABCB1—Methotrexate—psoriatic arthritis	0.0372	0.0478	CbGbCtD
Reboxetine—CYP3A4—Dexamethasone—psoriatic arthritis	0.0277	0.0357	CbGbCtD
Reboxetine—Vertigo—Prednisolone—psoriatic arthritis	0.000554	0.00248	CcSEcCtD
Reboxetine—Syncope—Prednisolone—psoriatic arthritis	0.000553	0.00248	CcSEcCtD
Reboxetine—Eye disorder—Dexamethasone—psoriatic arthritis	0.000552	0.00248	CcSEcCtD
Reboxetine—Eye disorder—Betamethasone—psoriatic arthritis	0.000552	0.00248	CcSEcCtD
Reboxetine—Loss of consciousness—Prednisolone—psoriatic arthritis	0.000542	0.00243	CcSEcCtD
Reboxetine—Angiopathy—Dexamethasone—psoriatic arthritis	0.000536	0.0024	CcSEcCtD
Reboxetine—Angiopathy—Betamethasone—psoriatic arthritis	0.000536	0.0024	CcSEcCtD
Reboxetine—Hypertension—Prednisolone—psoriatic arthritis	0.000532	0.00239	CcSEcCtD
Reboxetine—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.000526	0.00236	CcSEcCtD
Reboxetine—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000525	0.00235	CcSEcCtD
Reboxetine—Bradycardia—Prednisone—psoriatic arthritis	0.000524	0.00235	CcSEcCtD
Reboxetine—Discomfort—Prednisolone—psoriatic arthritis	0.000518	0.00232	CcSEcCtD
Reboxetine—Hallucination—Prednisone—psoriatic arthritis	0.000512	0.0023	CcSEcCtD
Reboxetine—Malaise—Triamcinolone—psoriatic arthritis	0.000511	0.00229	CcSEcCtD
Reboxetine—Malaise—Methylprednisolone—psoriatic arthritis	0.00051	0.00229	CcSEcCtD
Reboxetine—Vertigo—Triamcinolone—psoriatic arthritis	0.000509	0.00228	CcSEcCtD
Reboxetine—Syncope—Triamcinolone—psoriatic arthritis	0.000508	0.00228	CcSEcCtD
Reboxetine—Vertigo—Methylprednisolone—psoriatic arthritis	0.000508	0.00228	CcSEcCtD
Reboxetine—Syncope—Methylprednisolone—psoriatic arthritis	0.000507	0.00227	CcSEcCtD
Reboxetine—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000506	0.00227	CcSEcCtD
Reboxetine—Dysuria—Methotrexate—psoriatic arthritis	0.000502	0.00225	CcSEcCtD
Reboxetine—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000498	0.00223	CcSEcCtD
Reboxetine—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000497	0.00223	CcSEcCtD
Reboxetine—Shock—Prednisolone—psoriatic arthritis	0.000495	0.00222	CcSEcCtD
Reboxetine—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.000495	0.00222	CcSEcCtD
Reboxetine—Tachycardia—Prednisolone—psoriatic arthritis	0.000491	0.0022	CcSEcCtD
Reboxetine—Hypertension—Triamcinolone—psoriatic arthritis	0.000489	0.00219	CcSEcCtD
Reboxetine—Hypertension—Methylprednisolone—psoriatic arthritis	0.000488	0.00219	CcSEcCtD
Reboxetine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000486	0.00218	CcSEcCtD
Reboxetine—Eye disorder—Prednisone—psoriatic arthritis	0.000481	0.00216	CcSEcCtD
Reboxetine—Anxiety—Methylprednisolone—psoriatic arthritis	0.00048	0.00215	CcSEcCtD
Reboxetine—Infestation—Methotrexate—psoriatic arthritis	0.000479	0.00215	CcSEcCtD
Reboxetine—Infestation NOS—Methotrexate—psoriatic arthritis	0.000479	0.00215	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000478	0.00214	CcSEcCtD
Reboxetine—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000477	0.00214	CcSEcCtD
Reboxetine—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000477	0.00214	CcSEcCtD
Reboxetine—Discomfort—Triamcinolone—psoriatic arthritis	0.000477	0.00214	CcSEcCtD
Reboxetine—Discomfort—Methylprednisolone—psoriatic arthritis	0.000476	0.00213	CcSEcCtD
Reboxetine—Dry mouth—Triamcinolone—psoriatic arthritis	0.000472	0.00212	CcSEcCtD
Reboxetine—Angiopathy—Prednisone—psoriatic arthritis	0.000467	0.00209	CcSEcCtD
Reboxetine—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000466	0.00209	CcSEcCtD
Reboxetine—Confusional state—Methylprednisolone—psoriatic arthritis	0.000465	0.00209	CcSEcCtD
Reboxetine—Immune system disorder—Prednisone—psoriatic arthritis	0.000465	0.00208	CcSEcCtD
Reboxetine—Malaise—Dexamethasone—psoriatic arthritis	0.000464	0.00208	CcSEcCtD
Reboxetine—Malaise—Betamethasone—psoriatic arthritis	0.000464	0.00208	CcSEcCtD
Reboxetine—Vertigo—Dexamethasone—psoriatic arthritis	0.000462	0.00207	CcSEcCtD
Reboxetine—Vertigo—Betamethasone—psoriatic arthritis	0.000462	0.00207	CcSEcCtD
Reboxetine—Syncope—Betamethasone—psoriatic arthritis	0.000461	0.00207	CcSEcCtD
Reboxetine—Syncope—Dexamethasone—psoriatic arthritis	0.000461	0.00207	CcSEcCtD
Reboxetine—Infection—Triamcinolone—psoriatic arthritis	0.00046	0.00206	CcSEcCtD
Reboxetine—Sweating—Methotrexate—psoriatic arthritis	0.000459	0.00206	CcSEcCtD
Reboxetine—Infection—Methylprednisolone—psoriatic arthritis	0.000459	0.00206	CcSEcCtD
Reboxetine—Shock—Triamcinolone—psoriatic arthritis	0.000455	0.00204	CcSEcCtD
Reboxetine—Insomnia—Prednisolone—psoriatic arthritis	0.000455	0.00204	CcSEcCtD
Reboxetine—Shock—Methylprednisolone—psoriatic arthritis	0.000454	0.00204	CcSEcCtD
Reboxetine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000453	0.00203	CcSEcCtD
Reboxetine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000452	0.00203	CcSEcCtD
Reboxetine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000452	0.00203	CcSEcCtD
Reboxetine—Epistaxis—Methotrexate—psoriatic arthritis	0.000452	0.00203	CcSEcCtD
Reboxetine—Paraesthesia—Prednisolone—psoriatic arthritis	0.000452	0.00203	CcSEcCtD
Reboxetine—Tachycardia—Triamcinolone—psoriatic arthritis	0.000452	0.00202	CcSEcCtD
Reboxetine—Mental disorder—Prednisone—psoriatic arthritis	0.000451	0.00202	CcSEcCtD
Reboxetine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00045	0.00202	CcSEcCtD
Reboxetine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000448	0.00201	CcSEcCtD
Reboxetine—Malnutrition—Prednisone—psoriatic arthritis	0.000448	0.00201	CcSEcCtD
Reboxetine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000447	0.00201	CcSEcCtD
Reboxetine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000446	0.002	CcSEcCtD
Reboxetine—Hypertension—Betamethasone—psoriatic arthritis	0.000444	0.00199	CcSEcCtD
Reboxetine—Hypertension—Dexamethasone—psoriatic arthritis	0.000444	0.00199	CcSEcCtD
Reboxetine—Anxiety—Dexamethasone—psoriatic arthritis	0.000436	0.00196	CcSEcCtD
Reboxetine—Anxiety—Betamethasone—psoriatic arthritis	0.000436	0.00196	CcSEcCtD
Reboxetine—Discomfort—Dexamethasone—psoriatic arthritis	0.000433	0.00194	CcSEcCtD
Reboxetine—Discomfort—Betamethasone—psoriatic arthritis	0.000433	0.00194	CcSEcCtD
Reboxetine—Hypotension—Methylprednisolone—psoriatic arthritis	0.000431	0.00193	CcSEcCtD
Reboxetine—Pharyngitis—Methotrexate—psoriatic arthritis	0.000427	0.00191	CcSEcCtD
Reboxetine—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000425	0.0019	CcSEcCtD
Reboxetine—Urethral disorder—Methotrexate—psoriatic arthritis	0.000422	0.00189	CcSEcCtD
Reboxetine—Insomnia—Triamcinolone—psoriatic arthritis	0.000418	0.00188	CcSEcCtD
Reboxetine—Insomnia—Methylprednisolone—psoriatic arthritis	0.000417	0.00187	CcSEcCtD
Reboxetine—Infection—Betamethasone—psoriatic arthritis	0.000417	0.00187	CcSEcCtD
Reboxetine—Infection—Dexamethasone—psoriatic arthritis	0.000417	0.00187	CcSEcCtD
Reboxetine—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000416	0.00186	CcSEcCtD
Reboxetine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000415	0.00186	CcSEcCtD
Reboxetine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000415	0.00186	CcSEcCtD
Reboxetine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000414	0.00186	CcSEcCtD
Reboxetine—Visual impairment—Methotrexate—psoriatic arthritis	0.000414	0.00186	CcSEcCtD
Reboxetine—Anaemia—Prednisone—psoriatic arthritis	0.000414	0.00186	CcSEcCtD
Reboxetine—Shock—Betamethasone—psoriatic arthritis	0.000413	0.00185	CcSEcCtD
Reboxetine—Shock—Dexamethasone—psoriatic arthritis	0.000413	0.00185	CcSEcCtD
Reboxetine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000412	0.00185	CcSEcCtD
Reboxetine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000412	0.00185	CcSEcCtD
Reboxetine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000412	0.00185	CcSEcCtD
Reboxetine—Agitation—Prednisone—psoriatic arthritis	0.000412	0.00185	CcSEcCtD
Reboxetine—Tachycardia—Dexamethasone—psoriatic arthritis	0.00041	0.00184	CcSEcCtD
Reboxetine—Tachycardia—Betamethasone—psoriatic arthritis	0.00041	0.00184	CcSEcCtD
Reboxetine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000407	0.00183	CcSEcCtD
Reboxetine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000406	0.00182	CcSEcCtD
Reboxetine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000406	0.00182	CcSEcCtD
Reboxetine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000406	0.00182	CcSEcCtD
Reboxetine—Malaise—Prednisone—psoriatic arthritis	0.000404	0.00181	CcSEcCtD
Reboxetine—Vertigo—Prednisone—psoriatic arthritis	0.000402	0.0018	CcSEcCtD
Reboxetine—Eye disorder—Methotrexate—psoriatic arthritis	0.000402	0.0018	CcSEcCtD
Reboxetine—Syncope—Prednisone—psoriatic arthritis	0.000402	0.0018	CcSEcCtD
Reboxetine—Tinnitus—Methotrexate—psoriatic arthritis	0.000401	0.0018	CcSEcCtD
Reboxetine—Anorexia—Dexamethasone—psoriatic arthritis	0.0004	0.00179	CcSEcCtD
Reboxetine—Anorexia—Betamethasone—psoriatic arthritis	0.0004	0.00179	CcSEcCtD
Reboxetine—Urticaria—Prednisolone—psoriatic arthritis	0.0004	0.00179	CcSEcCtD
Reboxetine—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000399	0.00179	CcSEcCtD
Reboxetine—Loss of consciousness—Prednisone—psoriatic arthritis	0.000394	0.00177	CcSEcCtD
Reboxetine—Hypotension—Betamethasone—psoriatic arthritis	0.000392	0.00176	CcSEcCtD
Reboxetine—Hypotension—Dexamethasone—psoriatic arthritis	0.000392	0.00176	CcSEcCtD
Reboxetine—Angiopathy—Methotrexate—psoriatic arthritis	0.00039	0.00175	CcSEcCtD
Reboxetine—Immune system disorder—Methotrexate—psoriatic arthritis	0.000388	0.00174	CcSEcCtD
Reboxetine—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000388	0.00174	CcSEcCtD
Reboxetine—Hypertension—Prednisone—psoriatic arthritis	0.000387	0.00173	CcSEcCtD
Reboxetine—Chills—Methotrexate—psoriatic arthritis	0.000386	0.00173	CcSEcCtD
Reboxetine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000381	0.00171	CcSEcCtD
Reboxetine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00038	0.00171	CcSEcCtD
Reboxetine—Anxiety—Prednisone—psoriatic arthritis	0.00038	0.0017	CcSEcCtD
Reboxetine—Insomnia—Dexamethasone—psoriatic arthritis	0.00038	0.0017	CcSEcCtD
Reboxetine—Insomnia—Betamethasone—psoriatic arthritis	0.00038	0.0017	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000379	0.0017	CcSEcCtD
Reboxetine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000377	0.00169	CcSEcCtD
Reboxetine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000377	0.00169	CcSEcCtD
Reboxetine—Paraesthesia—Betamethasone—psoriatic arthritis	0.000377	0.00169	CcSEcCtD
Reboxetine—Discomfort—Prednisone—psoriatic arthritis	0.000377	0.00169	CcSEcCtD
Reboxetine—Mental disorder—Methotrexate—psoriatic arthritis	0.000377	0.00169	CcSEcCtD
Reboxetine—Malnutrition—Methotrexate—psoriatic arthritis	0.000374	0.00168	CcSEcCtD
Reboxetine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000371	0.00166	CcSEcCtD
Reboxetine—Dyspepsia—Betamethasone—psoriatic arthritis	0.000369	0.00166	CcSEcCtD
Reboxetine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000369	0.00166	CcSEcCtD
Reboxetine—Urticaria—Triamcinolone—psoriatic arthritis	0.000368	0.00165	CcSEcCtD
Reboxetine—Urticaria—Methylprednisolone—psoriatic arthritis	0.000367	0.00164	CcSEcCtD
Reboxetine—Dysgeusia—Methotrexate—psoriatic arthritis	0.000367	0.00164	CcSEcCtD
Reboxetine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000366	0.00164	CcSEcCtD
Reboxetine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000365	0.00164	CcSEcCtD
Reboxetine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000365	0.00164	CcSEcCtD
Reboxetine—Decreased appetite—Betamethasone—psoriatic arthritis	0.000365	0.00164	CcSEcCtD
Reboxetine—Infection—Prednisone—psoriatic arthritis	0.000363	0.00163	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000362	0.00162	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000362	0.00162	CcSEcCtD
Reboxetine—Shock—Prednisone—psoriatic arthritis	0.00036	0.00161	CcSEcCtD
Reboxetine—Nervous system disorder—Prednisone—psoriatic arthritis	0.000358	0.00161	CcSEcCtD
Reboxetine—Tachycardia—Prednisone—psoriatic arthritis	0.000357	0.0016	CcSEcCtD
Reboxetine—Skin disorder—Prednisone—psoriatic arthritis	0.000355	0.00159	CcSEcCtD
Reboxetine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000353	0.00158	CcSEcCtD
Reboxetine—Anorexia—Prednisone—psoriatic arthritis	0.000348	0.00156	CcSEcCtD
Reboxetine—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000347	0.00156	CcSEcCtD
Reboxetine—Anaemia—Methotrexate—psoriatic arthritis	0.000346	0.00155	CcSEcCtD
Reboxetine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000346	0.00155	CcSEcCtD
Reboxetine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000346	0.00155	CcSEcCtD
Reboxetine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000343	0.00154	CcSEcCtD
Reboxetine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000343	0.00154	CcSEcCtD
Reboxetine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000341	0.00153	CcSEcCtD
Reboxetine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00034	0.00152	CcSEcCtD
Reboxetine—Malaise—Methotrexate—psoriatic arthritis	0.000338	0.00151	CcSEcCtD
Reboxetine—Vertigo—Methotrexate—psoriatic arthritis	0.000336	0.00151	CcSEcCtD
Reboxetine—Leukopenia—Methotrexate—psoriatic arthritis	0.000335	0.0015	CcSEcCtD
Reboxetine—Urticaria—Dexamethasone—psoriatic arthritis	0.000333	0.0015	CcSEcCtD
Reboxetine—Urticaria—Betamethasone—psoriatic arthritis	0.000333	0.0015	CcSEcCtD
Reboxetine—Dizziness—Prednisolone—psoriatic arthritis	0.000333	0.00149	CcSEcCtD
Reboxetine—Asthenia—Triamcinolone—psoriatic arthritis	0.000332	0.00149	CcSEcCtD
Reboxetine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000332	0.00149	CcSEcCtD
Reboxetine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000332	0.00149	CcSEcCtD
Reboxetine—Body temperature increased—Betamethasone—psoriatic arthritis	0.000332	0.00149	CcSEcCtD
Reboxetine—Abdominal pain—Betamethasone—psoriatic arthritis	0.000332	0.00149	CcSEcCtD
Reboxetine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000331	0.00148	CcSEcCtD
Reboxetine—Insomnia—Prednisone—psoriatic arthritis	0.000331	0.00148	CcSEcCtD
Reboxetine—Paraesthesia—Prednisone—psoriatic arthritis	0.000328	0.00147	CcSEcCtD
Reboxetine—Dyspepsia—Prednisone—psoriatic arthritis	0.000322	0.00144	CcSEcCtD
Reboxetine—Chest pain—Methotrexate—psoriatic arthritis	0.000319	0.00143	CcSEcCtD
Reboxetine—Decreased appetite—Prednisone—psoriatic arthritis	0.000318	0.00142	CcSEcCtD
Reboxetine—Rash—Prednisolone—psoriatic arthritis	0.000317	0.00142	CcSEcCtD
Reboxetine—Dermatitis—Prednisolone—psoriatic arthritis	0.000317	0.00142	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000316	0.00142	CcSEcCtD
Reboxetine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000316	0.00142	CcSEcCtD
Reboxetine—Headache—Prednisolone—psoriatic arthritis	0.000315	0.00141	CcSEcCtD
Reboxetine—Discomfort—Methotrexate—psoriatic arthritis	0.000315	0.00141	CcSEcCtD
Reboxetine—Constipation—Prednisone—psoriatic arthritis	0.000313	0.0014	CcSEcCtD
Reboxetine—Confusional state—Methotrexate—psoriatic arthritis	0.000308	0.00138	CcSEcCtD
Reboxetine—Dizziness—Triamcinolone—psoriatic arthritis	0.000306	0.00137	CcSEcCtD
Reboxetine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000305	0.00137	CcSEcCtD
Reboxetine—Infection—Methotrexate—psoriatic arthritis	0.000304	0.00136	CcSEcCtD
Reboxetine—Feeling abnormal—Prednisone—psoriatic arthritis	0.000301	0.00135	CcSEcCtD
Reboxetine—Asthenia—Betamethasone—psoriatic arthritis	0.000301	0.00135	CcSEcCtD
Reboxetine—Asthenia—Dexamethasone—psoriatic arthritis	0.000301	0.00135	CcSEcCtD
Reboxetine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.0003	0.00134	CcSEcCtD
Reboxetine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000299	0.00134	CcSEcCtD
Reboxetine—Nausea—Prednisolone—psoriatic arthritis	0.000299	0.00134	CcSEcCtD
Reboxetine—Skin disorder—Methotrexate—psoriatic arthritis	0.000297	0.00133	CcSEcCtD
Reboxetine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000295	0.00132	CcSEcCtD
Reboxetine—Vomiting—Triamcinolone—psoriatic arthritis	0.000294	0.00132	CcSEcCtD
Reboxetine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000293	0.00132	CcSEcCtD
Reboxetine—Rash—Triamcinolone—psoriatic arthritis	0.000292	0.00131	CcSEcCtD
Reboxetine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000291	0.00131	CcSEcCtD
Reboxetine—Anorexia—Methotrexate—psoriatic arthritis	0.000291	0.00131	CcSEcCtD
Reboxetine—Rash—Methylprednisolone—psoriatic arthritis	0.000291	0.00131	CcSEcCtD
Reboxetine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000291	0.0013	CcSEcCtD
Reboxetine—Urticaria—Prednisone—psoriatic arthritis	0.00029	0.0013	CcSEcCtD
Reboxetine—Headache—Triamcinolone—psoriatic arthritis	0.00029	0.0013	CcSEcCtD
Reboxetine—Headache—Methylprednisolone—psoriatic arthritis	0.000289	0.0013	CcSEcCtD
Reboxetine—Abdominal pain—Prednisone—psoriatic arthritis	0.000289	0.0013	CcSEcCtD
Reboxetine—Body temperature increased—Prednisone—psoriatic arthritis	0.000289	0.0013	CcSEcCtD
Reboxetine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000287	0.00129	CcSEcCtD
Reboxetine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000287	0.00129	CcSEcCtD
Reboxetine—Hypotension—Methotrexate—psoriatic arthritis	0.000285	0.00128	CcSEcCtD
Reboxetine—Dizziness—Dexamethasone—psoriatic arthritis	0.000278	0.00124	CcSEcCtD
Reboxetine—Dizziness—Betamethasone—psoriatic arthritis	0.000278	0.00124	CcSEcCtD
Reboxetine—Insomnia—Methotrexate—psoriatic arthritis	0.000276	0.00124	CcSEcCtD
Reboxetine—Nausea—Triamcinolone—psoriatic arthritis	0.000275	0.00123	CcSEcCtD
Reboxetine—Paraesthesia—Methotrexate—psoriatic arthritis	0.000274	0.00123	CcSEcCtD
Reboxetine—Nausea—Methylprednisolone—psoriatic arthritis	0.000274	0.00123	CcSEcCtD
Reboxetine—Dyspnoea—Methotrexate—psoriatic arthritis	0.000272	0.00122	CcSEcCtD
Reboxetine—Somnolence—Methotrexate—psoriatic arthritis	0.000272	0.00122	CcSEcCtD
Reboxetine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000269	0.00121	CcSEcCtD
Reboxetine—Dyspepsia—Methotrexate—psoriatic arthritis	0.000269	0.00121	CcSEcCtD
Reboxetine—Vomiting—Betamethasone—psoriatic arthritis	0.000267	0.0012	CcSEcCtD
Reboxetine—Vomiting—Dexamethasone—psoriatic arthritis	0.000267	0.0012	CcSEcCtD
Reboxetine—Decreased appetite—Methotrexate—psoriatic arthritis	0.000266	0.00119	CcSEcCtD
Reboxetine—Rash—Betamethasone—psoriatic arthritis	0.000265	0.00119	CcSEcCtD
Reboxetine—Rash—Dexamethasone—psoriatic arthritis	0.000265	0.00119	CcSEcCtD
Reboxetine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000264	0.00119	CcSEcCtD
Reboxetine—Dermatitis—Betamethasone—psoriatic arthritis	0.000264	0.00119	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000264	0.00118	CcSEcCtD
Reboxetine—Headache—Dexamethasone—psoriatic arthritis	0.000263	0.00118	CcSEcCtD
Reboxetine—Headache—Betamethasone—psoriatic arthritis	0.000263	0.00118	CcSEcCtD
Reboxetine—Asthenia—Prednisone—psoriatic arthritis	0.000262	0.00118	CcSEcCtD
Reboxetine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000252	0.00113	CcSEcCtD
Reboxetine—Diarrhoea—Prednisone—psoriatic arthritis	0.00025	0.00112	CcSEcCtD
Reboxetine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00025	0.00112	CcSEcCtD
Reboxetine—Nausea—Dexamethasone—psoriatic arthritis	0.000249	0.00112	CcSEcCtD
Reboxetine—Nausea—Betamethasone—psoriatic arthritis	0.000249	0.00112	CcSEcCtD
Reboxetine—Urticaria—Methotrexate—psoriatic arthritis	0.000243	0.00109	CcSEcCtD
Reboxetine—Dizziness—Prednisone—psoriatic arthritis	0.000242	0.00108	CcSEcCtD
Reboxetine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000242	0.00108	CcSEcCtD
Reboxetine—Body temperature increased—Methotrexate—psoriatic arthritis	0.000242	0.00108	CcSEcCtD
Reboxetine—Vomiting—Prednisone—psoriatic arthritis	0.000232	0.00104	CcSEcCtD
Reboxetine—Rash—Prednisone—psoriatic arthritis	0.00023	0.00103	CcSEcCtD
Reboxetine—Dermatitis—Prednisone—psoriatic arthritis	0.00023	0.00103	CcSEcCtD
Reboxetine—Headache—Prednisone—psoriatic arthritis	0.000229	0.00103	CcSEcCtD
Reboxetine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000225	0.00101	CcSEcCtD
Reboxetine—Asthenia—Methotrexate—psoriatic arthritis	0.000219	0.000983	CcSEcCtD
Reboxetine—Nausea—Prednisone—psoriatic arthritis	0.000217	0.000974	CcSEcCtD
Reboxetine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000209	0.000937	CcSEcCtD
Reboxetine—Dizziness—Methotrexate—psoriatic arthritis	0.000202	0.000906	CcSEcCtD
Reboxetine—Vomiting—Methotrexate—psoriatic arthritis	0.000194	0.000871	CcSEcCtD
Reboxetine—Rash—Methotrexate—psoriatic arthritis	0.000193	0.000864	CcSEcCtD
Reboxetine—Dermatitis—Methotrexate—psoriatic arthritis	0.000192	0.000863	CcSEcCtD
Reboxetine—Headache—Methotrexate—psoriatic arthritis	0.000191	0.000858	CcSEcCtD
Reboxetine—Nausea—Methotrexate—psoriatic arthritis	0.000181	0.000814	CcSEcCtD
